A non-benzene polycyclic aromatic hydrocarbon containing a diazapyr unit, its preparation method and application

The preparation of diazapentaheptacyclic fused polycyclic aromatic hydrocarbons via the (3+2) cyclization reaction of 1,3-dipoles solves the problem of synthesizing complex diazapentaene-based non-benzene polycyclic aromatic hydrocarbons, achieving high electron mobility and excellent solubility, and expanding their application in field-effect transistors.

CN123106677APending Publication Date: 2026-11-17INST OF CHEM CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510626369.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-05-15
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In the prior art, the synthesis methods of non-benzene polycyclic aromatic hydrocarbons containing diazazine units are complex, which limits the development of such materials, and their application in field-effect transistors is limited.

Method used

A three-step reaction was used to prepare fused polycyclic aromatic hydrocarbons (PAHs) consisting of diazapyridine and heptacyclic rings. The synthesis of non-benzene PAHs with diazapyridine units was achieved by utilizing the (3+2) cyclization reaction of 1,3-dipolar atoms in combination with metal catalysts and bases. The PAHs were then applied to field-effect transistors.

Benefits of technology

It achieves p-type semiconductor performance, with an electron mobility of 0.104 cm2V-1s-1 and an on/off ratio greater than 105. It has excellent electron transport and solubility properties and is suitable for optoelectronic functional materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106677A_ABST
    Figure CN123106677A_ABST
Patent Text Reader

Abstract

This invention provides a non-benzene polycyclic aromatic hydrocarbon containing a diazazanium unit, its preparation method, and its applications. Its structural formula is shown in Formula I. This invention achieves the synthesis of non-benzene polycyclic aromatic hydrocarbons containing a diazazanium unit through a 1,3-dipolar (3+2) cyclization reaction. This is of great significance for the compatibility of the reaction itself and for expanding the types and functional studies of non-benzene polycyclic aromatic hydrocarbons containing complex ring systems. Furthermore, the compound shown in Formula I provided by this invention exhibits excellent electron transport and solubility properties, which is beneficial for studying its semiconductor properties. The non-benzene polycyclic aromatic hydrocarbons containing complex ring systems synthesized by this invention all have the potential to serve as photoelectric and electromagnetic functional materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the development and semiconductor application of a non-benzene polycyclic aromatic hydrocarbon containing a diazazine unit, belonging to the fields of organic synthesis and optoelectronic materials. Background Technology

[0002] Polycyclic aromatic hydrocarbons (PAHs) have become widely used optoelectronic functional conjugated materials due to their unique π-electronic structure and physical properties. To modify the structure and thus improve the functionality of PAH materials, researchers have developed numerous strategies, including the introduction of non-benzene rings (e.g., five-, seven-, or eight-membered rings) and heteroatoms. In particular, non-benzene PAHs fused with five / seven-membered rings (formally known as azurite units) have emerged as emerging materials in the last five years. Due to their dynamic conformation, rich redox properties, narrow band gap, and redshift absorption, they have found wide applications in assembly and thermoelectric materials, near-infrared absorption, and semiconductors. Introducing heteroatoms into the five / seven-membered ring pairs can further enrich their redox properties and adjust their molecular configuration. Therefore, research on fused and nitrogen-containing five / seven-membered ring PAHs is of great significance for expanding the types and improving the overall performance of organic optoelectronic functional materials.

[0003] Currently, there are relatively few reported non-benzene polycyclic aromatic hydrocarbons containing diazazine units, and molecular design and material development in this field are still in their early stages. This is mainly because the construction of complex ring systems is difficult, and synthetic methods are limited, which greatly restricts the development of such materials.

[0004] The (3+2) cyclization reaction based on the 1,3-dipolar is simple and efficient, effectively shortening the reaction route and making it suitable for the synthesis of polycyclic aromatic hydrocarbons. However, this reaction is mainly focused on a limited number of monomers and is usually used for the construction of five-membered and six-membered ring systems. There are few reports on the construction of complex ring systems with multiple heteroatom doping. Summary of the Invention

[0005] This invention provides a non-benzene polycyclic aromatic hydrocarbon (NAz) containing a diazazene unit, its preparation method, and its application in field-effect transistors. This invention prepares the diazazene pentacyclic and heptacyclic fused polycyclic aromatic hydrocarbon NAz through a simple three-step reaction. NAz exhibits p-type semiconductor properties, with an electron mobility reaching a maximum of 0.104 cm⁻¹. 2 V -1 s -1 And the on / off ratios are all greater than 10. 5 .

[0006] The non-benzene polycyclic aromatic hydrocarbon (NAz) containing a diazazine unit provided by this invention has the structural formula shown in Formula I:

[0007]

[0008] In Formula I, R1 and R2 are each independently selected from at least one of the following: C1-C6 straight-chain or branched alkyl groups, halogens, cyano groups, nitro groups, and C1-C6 alkoxy groups.

[0009] Specifically, R1 and R2 are each independently tert-butyl.

[0010] The non-benzene polycyclic aromatic hydrocarbon (NAz) containing a diazazine unit shown in Formula I above is prepared by a method comprising the following steps:

[0011] 1) React the compound shown in Formula II and the compound shown in Formula III in organic solvent I and base to obtain the compound shown in Formula IV;

[0012] 2) The compound shown in formula IV is then subjected to a dehydrogenation reaction in organic solvent II in the presence of an oxidant to obtain the compound shown in formula V;

[0013] 3) Finally, the compound shown in formula V undergoes intramolecular coupling cyclization in organic solvent III in the presence of a metal catalyst, ligand, and base to give the compound shown in formula I.

[0014]

[0015] In Formula II, R1 is selected from at least one of the following: C1-C6 straight-chain or branched alkyl groups, halogens, cyano groups, nitro groups, and C1-C6 alkoxy groups;

[0016] In Formula III, R2 is selected from at least one of the following: C1-C6 straight-chain or branched alkyl groups, halogens, cyano groups, nitro groups, and C1-C6 alkoxy groups;

[0017] In Formulas IV and V, R1 and R2 are each independently selected from at least one of the following: C1-C6 straight-chain or branched alkyl groups, halogens, cyano groups, nitro groups, and C1-C6 alkoxy groups.

[0018] In step 1) of the above method, the reaction is carried out in a nitrogen or air atmosphere;

[0019] The reaction temperature can be 50-180℃, specifically 120℃;

[0020] The reaction time can be 3-24 hours, specifically 12 hours;

[0021] The organic solvent I can be selected from at least one of the following: toluene, o-xylene, chlorobenzene, tetrahydrofuran, dimethyl sulfoxide, dichloromethane, N,N-dimethylformamide, and N,N-dimethylacetamide, specifically at least one of toluene, dimethyl sulfoxide, and N,N-dimethylacetamide;

[0022] The molar ratio of the compound shown in Formula II to the compound shown in Formula III can be 1:0.1-4.0, specifically 1:2;

[0023] In step 2) of the above method, the oxidant may be selected from at least one of the following: ferric chloride, lead dioxide, manganese dioxide, p-tetrachlorobenzoquinone, o-tetrachlorobenzoquinone, and 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ), specifically 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ).

[0024] The molar ratio of the compound shown in Formula IV to the oxidant can be 1:1.0-10.0;

[0025] The organic solvent II may be selected from at least one of the following: toluene, o-xylene, chlorobenzene, tetrahydrofuran, dimethyl sulfoxide, dichloromethane, N,N-dimethylformamide, and N,N-dimethylacetamide, specifically at least one of toluene, dimethyl sulfoxide, and N,N-dimethylacetamide;

[0026] The temperature of the dehydrogenation reaction can be 50-180℃, specifically 120℃;

[0027] The dehydrogenation reaction can take 3-24 hours, specifically 12 hours;

[0028] In step 3) of the above method, the metal catalyst is a palladium catalyst;

[0029] The palladium catalyst may be selected from at least one of bis(dibenzylacetone)palladium, palladium acetate, palladium acetate, diphenylphosphine ferrocene palladium dichloride, tetraphenylphosphine palladium, dichlorodiphenylphosphine palladium, trifluoroacetate palladium, allyl palladium(II) chloride dimer, bis(tri-tert-butylphosphine)palladium and di-μ-chlorobis[5-chloro-2-[(4-chlorophenyl)(oxime)methyl]phenyl]palladium(II) dimer, specifically palladium acetate;

[0030] The ligand may be selected from at least one of tris[3,5-di(trifluoromethyl)phenyl]phosphine, 2-(dicyclohexylphosphine)biphenyl, 2-dicyclohexylphosphine-2',6'-dimethoxybiphenyl, tris(o-methylphenyl)phosphine, tris(p-phenylmethylphosphine) and tris(2,6-dimethoxyphenyl)phosphine, 1,4-bis(diphenylphosphine)butane, 4,5-bis(diphenylphosphine)-9,9-dimethyloxanthracene, 2-(dicyclohexylphosphine)-2'-(N,N-dimethylamine)biphenyl, di-tert-butylmethylphosphine tetrafluoroborate and 1,5-bis(diphenylphosphine)pentane, specifically di-tert-butylmethylphosphine tetrafluoroborate;

[0031] The base may be selected from at least one of lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, sodium acetate, potassium acetate, cesium acetate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, sodium dihydrogen phosphate, diisopropylethylamine, and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), specifically diisopropylethylamine and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU);

[0032] The molar ratios of the compound, metal catalyst, ligand, and base shown in Formula V can be: 1:0.1-5.0:0.3-20.0:1.0-20.0;

[0033] The organic solvent III can be selected from at least one of the following: toluene, o-xylene, chlorobenzene, tetrahydrofuran, dimethyl sulfoxide, dichloromethane, N,N-dimethylformamide, and N,N-dimethylacetamide, specifically at least one of toluene, dimethyl sulfoxide, and N,N-dimethylacetamide;

[0034] The intramolecular coupling cyclization temperature is 120-170℃;

[0035] The intramolecular coupling cyclization reaction takes 5-18 hours.

[0036] After the reaction is completed, the following processing steps are also included: After the reaction, the system is extracted with a separatory funnel to remove the reaction solvent, then the solvent is evaporated using a rotary evaporator, and then separated and purified by column chromatography, using petroleum ether / dichloromethane (10:1 to 3:1) as the eluent to obtain the compound shown in Formula IV; After the reaction, the system is evaporated with a rotary evaporator to remove the solvent, and then separated and purified by column chromatography, using petroleum ether / dichloromethane (10:1 to 1:2) as the eluent to obtain the compound shown in Formula V; After the reaction, the system is evaporated with a rotary evaporator to remove the solvent, and then separated and purified by column chromatography, using petroleum ether / dichloromethane (10:1 to 1:2) as the eluent to obtain the compound shown in Formula I.

[0037] This invention also provides the application of the compound of Formula I as a photoelectric and electromagnetic functional material.

[0038] The compound described in Formula I can be used in field-effect devices.

[0039] The field-effect device exhibits p-type charge transport performance.

[0040] The present invention also provides a field-effect device.

[0041] The present invention also provides a method for fabricating the above-mentioned field-effect device, comprising the following steps: sublimating the compound shown in Formula I onto substrates at different temperatures to fabricate the single-crystal field-effect device;

[0042] The above-mentioned field-effect device is fabricated by physical vapor deposition, with a sublimation temperature of 250-270℃, a crystal thickness of approximately 60-200nm, and a pressure of 21Pa.

[0043] The field-effect device was fabricated and tested in a nitrogen atmosphere.

[0044] The substrate is a commonly used substrate known in the art, and the electrode is a gold film electrode. After the Si / SiO2 substrate is modified with octadecyltrichlorosilane (OTS) and cleaned, it is immersed in a p-methylthiophenol acetonitrile solution for 10 hours.

[0045] This invention offers the following advantages: It achieves the synthesis of non-benzene polycyclic aromatic hydrocarbons (PAHs) with fused and diazazanium units through a (3+2) cyclization reaction of 1,3-dipolar atoms. This is of great significance for the compatibility of the reaction itself and for expanding the range of non-benzene PAHs containing complex ring systems and their functional applications. Furthermore, the compounds shown in Formula I provided by this invention exhibit excellent electron transport and solubility properties, which is beneficial for studying their semiconductor properties. The non-benzene PAHs containing complex ring systems synthesized by this invention all have the potential to serve as photoelectric and electromagnetic functional materials. Attached Figure Description

[0046] Figure 1 This is a flowchart illustrating the preparation process of the compound represented by Formula I of this invention.

[0047] Figure 2 (a) shows the crystal structure of the compound represented by Formula I, and (b) shows the crystal structure and packing of the compound represented by Formula I.

[0048] Figure 3 The UV-Vis absorption spectrum and fluorescence emission spectrum are those of the chloroform solution of the compound of formula I prepared in Example 1.

[0049] Figure 4 The cyclic voltammetry curves are for the compound of formula I prepared in Example 1.

[0050] Figure 5 The transfer curves and output curves of the compound of formula I prepared in Example 1 are shown; where (a) is the transfer curve and (b) is the output curve. Detailed Implementation

[0051] The present invention will now be described in further detail with reference to specific embodiments. The given embodiments are merely illustrative of the invention and not intended to limit its scope. The embodiments provided below can serve as a guide for further improvements by those skilled in the art and do not constitute a limitation on the invention in any way.

[0052] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, performed according to the techniques or conditions described in the literature in this field or according to the product instructions. Unless otherwise specified, the materials and reagents used in the following examples are commercially available.

[0053] Example I: Synthesis of the compound shown in Formula I (R1 and R2 are both tert-butyl groups)

[0054] Reference Figure 1 The reaction flow chart shown is used for preparation, and the specific reaction steps and conditions are as follows:

[0055] 10 ml of dimethyl sulfoxide and diisopropylethylamine (0.60 mmol) were added to the compounds shown in Formula II (R1 is tert-butyl, 0.15 mmol) and Formula III (R2 is tert-butyl, 0.30 mmol). The mixture was heated to 120 °C and reacted for 12 h, after which the reaction was stopped. The solvent was removed by extraction with water and dichloromethane, and the dichloromethane was removed by rotary evaporation. The mixture was then separated by column chromatography (eluting with petroleum ether / dichloromethane at volume ratios of 10:1, 8:1, 5:1, and 3:1) to obtain the compound shown in Formula IV (R1 and R2 are both tert-butyl). Add DDQ (1.1 mmol) and 10 ml of toluene to the compound shown in Formula IV (0.13 mmol), stir at 120 °C for 12 h. After the reaction stops, remove the solvent by rotary evaporation and separate by column chromatography (petroleum ether / dichloromethane as eluent, eluted at volume ratios of 10:1, 5:1, 1:1 and 1:2) to obtain the compound shown in Formula V (R1 and R2 are both tert-butyl). Finally, palladium acetate (0.07 mmol), di-tert-butylmethylphosphine tetrafluoroborate (0.21 mmol), 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, 1.4 mmol), and N,N-dimethylacetamide (2 ml) were added to the compound shown in Formula V (0.07 mmol). The mixture was stirred at 150 °C for 12 h. After the reaction was stopped, the solvent was removed by rotary evaporation, and the mixture was separated by column chromatography (petroleum ether / dichloromethane as eluent, eluted at volume ratios of 10:1, 5:1, 1:1, and 1:2) to obtain the compound shown in Formula I. (0.035 mmol, yield: 50%)

[0056] The structural verification data is as follows:

[0057] The compound shown in Formula I:

[0058] 1H NMR (400MHz, CDCl3): δ (ppm) = 8.66 (d, J = 8.0Hz, 2H), 8.61 (d, J = 8.0Hz, 2H), 8.38 (s, 2H), 8.30 (d, J = 7.6Hz, 2H), 7. 97(d,J=7.2Hz,2H),7.76(t,J=7.8Hz,4H),7.02(d,J=8.4Hz,2H),6.44(d,J=8.8Hz,2H),1.59(s,9H),1.14(s,9H).

[0059] 13 C NMR (101MHz, CDCl3): δ (ppm) = 141.27, 139.17, 131.75, 131.03, 130.60, 129.32, 128.99, 127.68, 126.27, 125 .53,125.40,124.15,123.87,122.69,122.09,120.43,120.00,114.92,114.40,35.74,33.82,32.19,31.53.

[0060] HR-MS: Calculated value is C 48 H 36 N2([M] + ): 640.29, mass spectrometry peak position: 640.2873;

[0061] The compound shown in Formula IV:

[0062] 1 H NMR (400MHz, CDCl3): δ=7.83(s,2H),7.77(d,J=7.6Hz,2H),7.69(d,J=8.0Hz,2H),7.33-7.28(m,5H),7.25–7.20(m,3H),7.18(d,J =8.0Hz,2H),6.98(t,J=7.4Hz,2H),6.74(d,J=7.6Hz,2H),5.06(d,J=6.8Hz,2H),3.36(d,J=6.8Hz,2H),1.47(s,9H),1.32(s,9H).

[0063] 13C NMR (101MHz, CDCl3): δ (ppm) = 146.38, 143.87, 143.54, 141.32, 138.11, 136.86, 133.49, 133.44, 132.51, 130.90, 128.9 2,128.52,127.97,127.13,126.17,125.49,121.65,121.63,121.54,114.15,65.70,52.80,34.69,34.08,31.71,31.69.

[0064] HR-MS: Calculated value is C 48 H 42 Cl2N2([M] + ):716.27, mass spectrometry peak position: 717.2798.

[0065] The compound shown in Formula V:

[0066] 1 H NMR (400MHz, CD2Cl2): δ (ppm) = 8.37 (s, 2H), 8.30 (t, J = 4.8Hz, 2H), 7.66 (d, J = 8.0Hz, 2H), 7.52–7.46 (m, 4H), 7.4 2(t,J=8.0Hz,4H),7.17(t,J=7.6Hz,2H),7.11(d,J=9.2Hz,2H),6.76(d,J=8.4Hz,2H),1.56(s,9H),1.21(s,9H).

[0067] 13 C NMR (101MHz, CDCl3): δ (ppm) = 146.76, 145.30, 143.54, 139.51, 136.26, 130.95, 130.87, 130.84, 130.05, 129.66, 128 .60,127.45,126.53,125.77,125.71,124.38,121.56,121.51,119.52,118.92,111.31,35.40,33.89,31.89,31.71.

[0068] HR-MS: Calculated value is C 48 H 38 Cl2N2([M] + ):712.24, mass spectrometry peak position: 712.2461.

[0069] As can be seen from the above, the structure of the product is correct.

[0070] Example 2: Crystal structure and packing of the compound shown in Formula I (R1 and R2 are both tert-butyl).

[0071] Preparation of crystals: The compound shown in Formula I was dissolved in chloroform solution, and methanol was slowly diffused into the chloroform solution by diffusion.

[0072] The crystal structure and packing of the compounds of this invention are as follows: Figure 2 As shown, the compound NAz represented by Formula I has a certain molecular curvature and bowl-shaped depth, the depths of which are respectively and It is defined as the distance between the plane of the five atoms on the central pyrazole ring, the plane formed by the terminal carbon atom (C6) of the central corannulene radial bond, and the plane of the five carbon atoms (C1-C5) at the edge. NAz exhibits a fishbone-like stacking, with strong CH…π interactions between molecules, and the CH…π distance is...

[0073] Example 3: UV-Vis absorption and fluorescence emission spectra of the compound of Formula I (R1 and R2 are both tert-butyl) in chloroform solution.

[0074] The compound of Formula I of this invention was dissolved in a variety of organic solvents, including chloroform, o-dichlorobenzene, 1,1,2,2-tetrachloroethane, and other solvents such as toluene. The compound of this invention exhibits good solubility in chlorinated solvents. The absorption and emission spectra of the solution were measured by dissolving the compound of Formula I in a chloroform solution (concentration 0.01 mmol / L). Figure 3 As shown. By Figure 3 It can be seen that the maximum absorption wavelength and the maximum emission wavelength of NAZ are 440nm and 503nm, respectively.

[0075] Example 4: Measurement of frontline orbital levels (HOMO) using cyclic voltammetry

[0076] The electrochemical properties of the compound of formula I (R1 being tert-butyl) prepared in Example 1 of this invention were tested using an electrochemical workstation. A three-electrode system was used, with a glassy carbon electrode as the working electrode, an Ag / AgCl electrode as the reference electrode, and a platinum wire electrode as the counter electrode. Cyclic voltammetric characteristics of an ultradry dichloromethane solution of NAz were tested under conditions of tetrabutylammonium hexafluorophosphate as the supporting electrolyte, ferrocene as the internal standard, and a scan rate of 100 mV / s. Figure 4 As shown. By Figure 4 It can be seen that NAz exhibits three reversible reduction peaks, and the HOMO level is -5.09V.

[0077] Example 5: Fabrication of Field-Effect Devices

[0078] NAZ crystals were prepared by physical vapor deposition (PVT), and their solid-state semiconductor properties were investigated. NAZ microcrystals were grown on a Si / SiO2 substrate modified with trichloro(octadecyl)silane (OTS) using PVT at a deposition temperature of 260 °C. These microcrystals were then used to fabricate bottom-gate / top-contact (BGTC) field-effect transistors (FETs), with the source and drain electrodes fabricated using 30 nm Au as a mask. The compound-based FETs were thus fabricated, and their field-effect properties were tested.

[0079] Its corresponding output curve (a) and transfer curve (b) are as follows: Figure 5 As shown, the NAZ crystal exhibits typical p-type semiconductor behavior, with the highest hole mobility reaching 0.104 cm⁻¹. 2 V -1 s -1 The current on / off ratio reaches 10. 5 This suggests that introducing diazazine units into polycyclic aromatic hydrocarbons may be an effective method for constructing high-mobility semiconductor materials.

[0080] The present invention has been described in detail above. Those skilled in the art will recognize that the invention can be practiced in a wide range of ways with equivalent parameters, concentrations, and conditions without departing from its spirit and scope, and without requiring unnecessary experiments. While specific embodiments have been provided, it should be understood that further modifications can be made to the invention. In summary, according to the principles of the invention, this application is intended to include any changes, uses, or improvements to the invention, including changes made using conventional techniques known in the art that depart from the scope disclosed herein.

Claims

1. A non-benzene polycyclic aromatic hydrocarbon containing a diazazanol unit, the structural formula of which is shown in Formula I: In Formula I, R1 and R2 are each independently selected from at least one of the following: C1-C6 straight-chain or branched alkyl groups, halogens, cyano groups, nitro groups, and C1-C6 alkoxy groups.

2. A method for preparing the non-benzene polycyclic aromatic hydrocarbon containing a diazazolium unit as described in claim 1, comprising the following steps: 1) reacting the compound shown in formula II and the compound shown in formula III in organic solvent I and a base to obtain the compound shown in formula IV; 2) The compound shown in formula IV is then subjected to a dehydrogenation reaction in organic solvent II in the presence of an oxidant to obtain the compound shown in formula V; 3) Finally, the compound shown in formula V undergoes intramolecular coupling cyclization in organic solvent III in the presence of a metal catalyst, ligand, and base to give the compound shown in formula I. In Formula II, R1 is selected from at least one of the following: C1-C6 straight-chain or branched alkyl groups, halogens, cyano groups, nitro groups, and C1-C6 alkoxy groups; In Formula III, R2 is selected from at least one of the following: C1-C6 straight-chain or branched alkyl groups, halogens, cyano groups, nitro groups, and C1-C6 alkoxy groups; In Formulas IV and V, R1 and R2 are each independently selected from at least one of the following: C1-C6 straight-chain or branched alkyl groups, halogens, cyano groups, nitro groups, and C1-C6 alkoxy groups.

3. The method according to claim 2, characterized in that, In step 1), the reaction temperature is 50-180℃; The reaction time is 3-24 hours; The organic solvent I is selected from at least one of toluene, o-xylene, chlorobenzene, tetrahydrofuran, dimethyl sulfoxide, dichloromethane, N,N-dimethylformamide, and N,N-dimethylacetamide, specifically at least one of toluene, dimethyl sulfoxide, and N,N-dimethylacetamide. The molar ratio of the compound shown in Formula II to the compound shown in Formula III is 1:0.1-4.

0.

4. The method according to claim 2, characterized in that, In step 2), the oxidant is selected from at least one of the following: ferric chloride, lead dioxide, manganese dioxide, p-tetrachlorobenzoquinone, o-tetrachlorobenzoquinone, and 2,3-dichloro-5,6-dicyanobenzoquinone; The molar ratio of the compound shown in Formula IV to the oxidant is 1:1.0-10.0; The organic solvent II is selected from at least one of the following: toluene, o-xylene, chlorobenzene, tetrahydrofuran, dimethyl sulfoxide, dichloromethane, N,N-dimethylformamide, and N,N-dimethylacetamide; The temperature of the dehydrogenation reaction is 50-180℃; The dehydrogenation reaction takes 3-24 hours.

5. The method according to claim 2, characterized in that, In step 3), the metal catalyst is a palladium catalyst; The palladium catalyst is selected from at least one of bis(dibenzylacetone)palladium, palladium acetate, palladium acetate, diphenylphosphine ferrocene palladium dichloride, tetraphenylphosphine palladium, dichlorodiphenylphosphine palladium, trifluoroacetate palladium, allyl palladium(II) dimer, bis(tri-tert-butylphosphine)palladium, and di-μ-chlorobis[5-chloro-2-[(4-chlorophenyl)(oxime)methyl]phenyl]palladium(II) dimer; The ligand is selected from at least one of tris[3,5-di(trifluoromethyl)phenyl]phosphine, 2-(dicyclohexylphosphine)biphenyl, 2-dicyclohexylphosphine-2',6'-dimethoxybiphenyl, tris(o-methylphenyl)phosphine, tris(p-phenylmethylphosphine) and tris(2,6-dimethoxyphenyl)phosphine, 1,4-bis(diphenylphosphine)butane, 4,5-bis(diphenylphosphine)-9,9-dimethyloxanthracene, 2-(dicyclohexylphosphine)-2'-(N,N-dimethylamine)biphenyl, di-tert-butylmethylphosphine tetrafluoroborate and 1,5-bis(diphenylphosphine)pentane; The base is selected from at least one of lithium hydroxide, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, cesium carbonate, sodium bicarbonate, potassium bicarbonate, sodium acetate, potassium acetate, cesium acetate, potassium dihydrogen phosphate, dipotassium hydrogen phosphate, sodium dihydrogen phosphate, diisopropylethylamine, and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU); The molar ratios of the compound shown in Formula V, the metal catalyst, the ligand, and the base are as follows: 1:0.1-5.0:0.3-20.0:1.0-20.

0.

6. The method according to claim 2, characterized in that, The intramolecular coupling cyclization temperature is 120-170℃; The intramolecular coupling cyclization reaction takes 5-18 hours.

7. The application of the compound of formula I according to claim 1 as a photoelectric and electromagnetic functional material.

8. The application according to claim 7, characterized in that, The compound described in Formula I is used in field-effect devices that exhibit p-type charge transport properties.

9. A field-effect device comprising a semiconductor material made of the compound of formula I in claim 1.

10. A method for preparing the field-effect device according to claim 9, comprising the following steps: sublimating the compound shown in Formula I onto substrates at different temperatures to prepare the single-crystal field-effect device.